🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary objective: \- to evaluate the efficacy of Sarilumab in participant...
Status
Completed
Location
Investigational Site Number 840006
Start Date
2010-02
Trial ID
NCT01061723
A potential application of therapeutic drug monitoring is to predict effica...
Status
Unknown
Location
Sint Maartenskliniek
Start Date
2020-07-31
Trial ID
NCT04251741
Treatments Being Tested
This is a randomized study of the safety and tolerability of multiple doses...
Status
Completed
Location
Multiple Locations
Start Date
2008-12
Trial ID
NCT01011959
Treatments Being Tested
Background: Mast cells help the body fight disease and heal wounds. People...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2019-06-19
Trial ID
NCT03770273
Sarilumab is an anti-interleukin-6 human monoclonal antibody, such as tocil...
Status
Withdrawn
Location
Divisione Clinicizzata di Malattie Infettive, ASST FBF-Sacco
Start Date
2021-01-01
Trial ID
NCT04386239
Treatments Being Tested
The global health emergency created by the rapid spread of the SARS-CoV-2 c...
Status
Completed
Location
Hospital Universitario de la Princesa
Start Date
2020-04-13
Trial ID
NCT04357808
Treatments Being Tested
Primary Objective: To describe the pharmacokinetic (PK) profile of sarilum...
Status
Completed
Location
Children's Hospital Los Angeles Site Number : 8400416
Start Date
2016-09-06
Trial ID
NCT02776735
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group, Pha...
Status
Recruiting
Location
Denver Arthritis Clinic - Lowry- Site Number : 8400001
Start Date
2026-05-12
Trial ID
NCT07286214
The study investigators are interested in learning more about how drugs, th...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2020-03-05
Trial ID
NCT04278404
Primary Objective: To describe the safety and tolerability, including labo...
Status
Completed
Location
Investigational Site Number 392001
Start Date
2015-05
Trial ID
NCT02404558
Treatments Being Tested